ANDREA MURPHY: Open Payments
NPI 1619484029 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 20 payments from 11 companies in 2025. Trend: 2023 $262 · 2024 $364 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Janssen Biotech, Inc. | 3 | $59 |
| ARRAY BIOPHARMA INC | 3 | $59 |
| ABBVIE INC. | 2 | $51 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Aveo Pharmaceuticals, Inc. | 1 | $21 |
| TerSera Therapeutics LLC | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Alexion Pharmaceuticals, Inc. | 1 | $17 |
Products named: LORBRENA, Belbuca, IMFINZI, EMRELIS, LYNOZYFIC, TALVEY, ELAHERE, FOTIVDA.
Industry payments across LA — which companies pay providers there.
